Vanguard Capital Management Establishes 5.15% Stake in Pacira BioSciences Inc

Vanguard Capital Management LLC has filed a Schedule 13G indicating a new substantial ownership stake in Pacira BioSciences Inc (PCRX). As of the event date on March 31, 2026, Vanguard reports beneficial ownership of 2,088,291 shares of common stock, representing 5.15% of the company. The filing, dated May 1, 2026, marks an increase from a previous 0% position, establishing Vanguard as a significant institutional investor. The reporting person, an investment adviser based in Malvern, PA, holds sole dispositive power over all 2,088,291 shares, while maintaining sole voting power over 304,242 shares. The holdings include securities managed by various Vanguard affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. This acquisition was made in the ordinary course of business and is not intended to influence or change the control of Pacira BioSciences. No other individual person’s interest in these securities exceeds 5% of the total shares outstanding.